MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹925 Cr | ₹1,019 Cr | ₹89 Cr | ₹48 Cr | ₹83 Cr |
What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹925 Cr |
| Mar2025 | ₹1,019 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹83 Cr |
How is Contingent Liabilities of MANKIND PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹925 Cr | -9.29 | |
| Mar2025 | ₹1,019 Cr | 1,045.33 | |
| Mar2024 | ₹89 Cr | 85.77 | |
| Mar2023 | ₹48 Cr | -41.97 | |
| Mar2022 | ₹83 Cr | - | |
Compare Contingent Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹106,428.0 Cr | 2.9% | 3.5% | -0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.9% |
3.5% |
-0.3% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses